Advantage Alpha Capital Partners’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-149,172
Closed -$914K 108
2025
Q3
$914K Sell
149,172
-59,755
-29% -$378K 0.28% 99
2025
Q2
$1.35M Sell
208,927
-18,146
-8% -$97.8K 0.36% 91
2025
Q1
$1.21M Sell
227,073
-8,654
-4% -$59.1K 0.3% 86
2024
Q4
$1.98M Buy
+235,727
New +$1.82M 0.47% 83

Other funds holding TBI

Advantage Alpha Capital Partners's TBI Position: Q4 2025 in Review

Advantage Alpha Capital Partners sold out of Trueblue (TBI) in Q4 2025, closing a stake of 149,172 shares — an estimated $914K sold.

Advantage Alpha Capital Partners first reported a position in TBI in Q4 2024 and held it in 4 quarters. The position peaked at $1.98M in Q4 2024. 110 funds tracked by Wall St. Rank hold TBI as of Q4 2025.

  • Advantage Alpha Capital Partners reported no remaining Trueblue position as of Q4 2025 after selling out during the quarter.
  • Advantage Alpha Capital Partners sold 149,172 Trueblue shares in Q4 2025, an estimated $914K.
  • Advantage Alpha Capital Partners first reported a position in Trueblue in Q4 2024 and held it in 4 quarters.
  • Advantage Alpha Capital Partners's Trueblue position peaked at $1.98M in Q4 2024.
  • 110 funds tracked by Wall St. Rank held Trueblue as of Q4 2025.

Based on Advantage Alpha Capital Partners's 13F filing for Q4 2025.